# Hidden Nicotine Exposure in Young Adult Black Men Using Cannabis Blunts

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/nicotine-exposure-cannabis-blunts-hidden-cotinine-levels/
> **Published:** 2026-04-03T09:01:27-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:31:13-04:00
> **Clinical Summary:** Explore nicotine exposure cannabis blunts and hidden cotinine levels among young adult Black men, revealing risks of nicotine addiction despite no tobacco use.

---

CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action.
🔬 Evidence Watch  |  CED Clinic
NicotineCannabisAddictionBlunts[Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/)

Journal
Drug and alcohol dependence

Study Type
[Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/)

Population
Human participants

Why This Matters

This study reveals significant hidden nicotine exposure among young Black men using cannabis blunts, with over half showing cotinine levels indicating recent nicotine consumption despite reporting no tobacco use. This finding has critical implications for addiction [risk assessment](https://cedclinic.com/ethical-legal-dilemmas-cannabis-use/) and informed consent in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/).

Clinical Summary
This cross-sectional study of 111 young adult Black men (ages 18-30) who reported cannabis blunt use but denied tobacco use found that 54.3% had salivary cotinine levels >10ng/mL, indicating nicotine exposure. Higher cotinine concentrations correlated with increased blunt use frequency. The study design included baseline surveys, timeline follow-back methodology, and paired saliva samples collected 10 hours apart. The findings suggest substantial unrecognized nicotine exposure through blunt wraps, which are tobacco leaf products, creating potential for nicotine dependence in patients who believe they are using only cannabis.

Dr. Caplan’s Take

“This confirms what I observe clinically – many patients using blunts are unknowingly developing nicotine dependence while believing they only use cannabis. This complicates both cessation counseling and our understanding of their substance use patterns.”

Clinical Perspective
🧠 Clinicians should routinely assess blunt use specifically, not just cannabis consumption generally, and counsel patients about hidden nicotine exposure from tobacco-based wraps. Consider cotinine testing when evaluating addiction risk in patients reporting cannabis-only use, and discuss alternative consumption methods to avoid unintended nicotine dependence.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Hidden%20nicotine%3A%20Cotinine%20levels%20among%20young%20adult%20Black%20men%20who%20smoke%20cannabis%20...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41719726/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41719726/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Hidden%20nicotine%3A%20Cotinine%20levels%20among%20young%20adult%20Black%20men%20who%20smoke%20cannabis%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41719726/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41719726/](https://pubmed.ncbi.nlm.nih.gov/41719726/)

Table of Contents

- [FAQ](#FAQ)[Can patients get nicotine exposure from smoking cannabis blunts even if they don’t use tobacco products?](#Can_patients_get_nicotine_exposure_from_smoking_cannabis_blunts_even_if_they_don8217t_use_tobacco_products)
- [How should clinicians screen for nicotine exposure in cannabis-using patients?](#How_should_clinicians_screen_for_nicotine_exposure_in_cannabis-using_patients)
- [What factors increase nicotine exposure risk in blunt users?](#What_factors_increase_nicotine_exposure_risk_in_blunt_users)
- [Should patients who smoke blunts be counseled about nicotine addiction risk?](#Should_patients_who_smoke_blunts_be_counseled_about_nicotine_addiction_risk)
- [How reliable is patient self-reporting for assessing tobacco exposure in cannabis users?](#How_reliable_is_patient_self-reporting_for_assessing_tobacco_exposure_in_cannabis_users)
- [Related](#Related)

## FAQ

#### Can patients get nicotine exposure from smoking cannabis blunts even if they don’t use tobacco products?

Yes, this study found that over half (54.3%) of young adult Black men who reported no tobacco use but smoked cannabis blunts had detectable cotinine levels above 10ng/mL in their saliva. This indicates significant nicotine exposure from the tobacco leaf wrappers used in blunt construction, even among self-reported non-tobacco users.

#### How should clinicians screen for nicotine exposure in cannabis-using patients?

Clinicians should specifically ask about blunt use patterns, not just traditional tobacco products, when assessing nicotine exposure risk. The study demonstrates that self-reported tobacco use may not accurately reflect actual nicotine exposure, as patients may not recognize blunt wrappers as a tobacco product.

#### What factors increase nicotine exposure risk in blunt users?

Higher cotinine concentrations were significantly associated with more frequent blunt use, suggesting a dose-response relationship. The method of blunt construction and frequency of use appear to be key determinants of nicotine exposure levels in cannabis users.

#### Should patients who smoke blunts be counseled about nicotine addiction risk?

Yes, patients should be informed that blunt use carries nicotine exposure and potential addiction risk due to the tobacco leaf wrappers. This is particularly important for patients who may not realize they are consuming tobacco products when using cannabis blunts.

#### How reliable is patient self-reporting for assessing tobacco exposure in cannabis users?

Self-reporting appears insufficient for accurately assessing nicotine exposure in cannabis users. This study found significant discordance between self-reported tobacco use and objective cotinine levels, suggesting that biochemical verification may be necessary for accurate assessment.

{“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Hidden nicotine: Cotinine levels among young adult Black men who smoke cannabis blunts.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41719726/”, “about”: “drug alcohol dependence clinical study hidden”, “isPartOf”: “Drug and alcohol dependence”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Hidden nicotine: Cotinine levels among young adult Black men who smoke cannabis blunts.](https://cedclinic.com/hidden-nicotine-exposure-cannabis-blunts-cotinine-study/)

A detailed clinical study revealing nicotine exposure through blunt use in young Black men, highlighting addiction risks.

[Read the full study](https://cedclinic.com/hidden-nicotine-exposure-cannabis-blunts-cotinine-study/)

[Perceived Safety of Cannabis Use During Pregnancy and Changes in Perception over Time (2017-2021)](https://cedclinic.com/perceived-cannabis-safety-pregnancy-survey-2017-2021/)

National survey exploring evolving perceptions of [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) during pregnancy among US adults.

[Explore survey findings](https://cedclinic.com/perceived-cannabis-safety-pregnancy-survey-2017-2021/)

[The effect of cannabis use on the time course of positive and negative affect in the daily life of youth.](https://cedclinic.com/cannabis-effects-youth-daily-mood-patterns/)

Study analyzing how [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) influences mood fluctuations in young people over time.

[Learn about mood impacts](https://cedclinic.com/cannabis-effects-youth-daily-mood-patterns/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
